S. Joel Marcus's most recent trade in Intra-Cellular Therapies Inc was a trade of 7,009 Common Stock done at an average price of $63.8 . Disclosure was reported to the exchange on Feb. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.79 per share. | 24 Feb 2025 | 7,009 | 48,238 (0%) | 0% | 63.8 | 447,104 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 7,009 | 0 | - | - | Stock Option (right to buy) | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 46,207 | 456,144 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2024 | 19,156 | 394,327 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 15,610 | 409,937 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 1,567 | 41,229 (0%) | 0% | - | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 1,567 | 0 | - | - | Restricted Stock Units | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 4,322 | 4,322 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 2,951 | 2,951 | - | - | Restricted Stock Units | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 498,414 (2%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Mar 2024 | 10,655 | 418,883 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.91 per share. | 29 Mar 2024 | 5,400 | 413,483 (0%) | 0% | 128.9 | 696,114 | Common Stock |
| Intra-Cellular Therapies Inc | Joel Marcus S. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.45 per share. | 26 Feb 2024 | 20,000 | 49,233 (0%) | 0% | 43.5 | 869,000 | Common Stock |
| Intra-Cellular Therapies Inc | Marcus Joel S. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | S. Joel Marcus | Director | Sale of securities on an exchange or to another person at price $ 69.07 per share. | 26 Feb 2024 | 17,658 | 39,961 (0%) | 0% | 69.1 | 1,219,638 | Common Stock |
| Intra-Cellular Therapies Inc | S. Marcus Joel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.48 per share. | 26 Feb 2024 | 16,757 | 65,990 (0%) | 0% | 55.5 | 929,678 | Common Stock |
| Intra-Cellular Therapies Inc | Marcus S. Joel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 16,757 | 0 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | S. Joel Marcus | Director | Sale of securities on an exchange or to another person at price $ 67.83 per share. | 26 Feb 2024 | 8,371 | 57,619 (0%) | 0% | 67.8 | 567,805 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel Marcus S. | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 118.92 per share. | 26 Feb 2024 | 7,500 | 429,538 (0%) | 0% | 118.9 | 891,900 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 69.60 per share. | 26 Feb 2024 | 299 | 39,662 (0%) | 0% | 69.6 | 20,810 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel Marcus S. | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 35,064 | 437,038 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Marcus S. Joel | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 3,000 | 401,974 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | S. Marcus Joel | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 47,620 | 398,974 (0%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2023 | 12,375 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 15 Sep 2023 | 12,375 | 453,414 (2%) | 0% | 1.1 | 12,994 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 7,009 | 7,009 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 1,567 | 1,567 | - | - | Restricted Stock Units | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 441,039 (2%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 122.20 per share. | 08 May 2023 | 7,500 | 351,354 (0%) | 0% | 122.2 | 916,500 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.59 per share. | 31 Mar 2023 | 10,015 | 358,854 (0%) | 0% | 125.6 | 1,257,784 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Mar 2023 | 6,507 | 368,869 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 168.00 per share. | 07 Feb 2023 | 9,000 | 388,729 (0%) | 0% | 168 | 1,512,000 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 160.68 per share. | 27 Jan 2023 | 5,608 | 397,729 (0%) | 0% | 160.7 | 901,093 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 24,051 | 403,337 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 42,260 | 379,286 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 50.82 per share. | 19 Dec 2022 | 5,000 | 29,233 (0%) | 0% | 50.8 | 254,100 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 12 Dec 2022 | 6,500 | 337,026 (0%) | 0% | 150 | 975,000 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 152.00 per share. | 05 Dec 2022 | 2,500 | 343,526 (0%) | 0% | 152 | 380,000 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 52.11 per share. | 07 Nov 2022 | 5,000 | 34,233 (0%) | 0% | 52.1 | 260,559 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 52.49 per share. | 07 Nov 2022 | 5,000 | 39,233 (0%) | 0% | 52.5 | 262,465 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 14,846 | 0 | - | - | Stock Option | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 59.22 per share. | 11 Aug 2022 | 10,000 | 44,233 (0%) | 0% | 59.2 | 592,200 | Common Stock |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 7,389 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 7,389 | 7,389 | - | - | Employee Stock Option (Right to Buy) | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 14,846 | 14,846 | - | - | Stock Option | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 16,757 | 16,757 | - | - | Stock Option (right to buy) | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 2,500 | 346,026 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 24,560 | 343,526 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 52.89 per share. | 07 Mar 2022 | 10,000 | 28,980 (0%) | 0% | 52.9 | 528,900 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 54.52 per share. | 07 Mar 2022 | 5,000 | 43,980 (0%) | 0% | 54.5 | 272,600 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 52.25 per share. | 07 Mar 2022 | 5,000 | 38,980 (0%) | 0% | 52.3 | 261,250 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2022 | 16,869 | 318,966 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 207.61 per share. | 09 Aug 2021 | 7,500 | 302,097 (0%) | 0% | 207.6 | 1,557,075 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 202.63 per share. | 02 Aug 2021 | 5,000 | 309,597 (0%) | 0% | 202.6 | 1,013,150 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 28 Jul 2021 | 15,000 | 314,597 (0%) | 0% | 200 | 3,000,000 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 200.02 per share. | 28 Jul 2021 | 5,000 | 329,597 (0%) | 0% | 200.0 | 1,000,100 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 14,846 | 14,846 | - | - | Stock Option | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 13,767 | 13,767 (0%) | 0% | - | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 13,767 | 0 | - | - | Restricted Stock Units | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 180.33 per share. | 03 May 2021 | 15,000 | 339,597 (0%) | 0% | 180.3 | 2,704,950 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 180.41 per share. | 03 May 2021 | 5,000 | 334,597 (0%) | 0% | 180.4 | 902,050 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Apr 2021 | 25,000 | 47,269 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 21,310 | 366,992 (0%) | 0% | 0 | Common Stock | |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 164.30 per share. | 31 Mar 2021 | 12,395 | 354,597 (0%) | 0% | 164.3 | 2,036,499 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2021 | 37,116 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.37 per share. | 25 Mar 2021 | 37,116 | 307,116 (0%) | 0% | 3.4 | 125,081 | Common Stock |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 12,882 | 0 | - | - | Stock Option (right to buy) | |
| MeiraGTx Holdings plc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.72 per share. | 15 Mar 2021 | 12,882 | 12,882 (0%) | 0% | 7.7 | 99,449 | Ordinary Shares |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2021 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.58 per share. | 02 Mar 2021 | 20,000 | 87,519 (0%) | 0% | 26.6 | 531,600 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 34.93 per share. | 02 Mar 2021 | 15,250 | 72,269 (0%) | 0% | 34.9 | 532,683 | Common Stock |
| Alexandria Real Estate Equities - REIT | Joel S. Marcus | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 21,251 | 345,682 (0%) | 0% | 0 | Common Stock | |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 34.27 per share. | 18 Dec 2020 | 10,000 | 270,000 (0%) | 0% | 34.3 | 342,738 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 30.35 per share. | 18 Dec 2020 | 10,000 | 290,000 (0%) | 0% | 30.4 | 303,521 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 38.27 per share. | 18 Dec 2020 | 8,412 | 300,000 (0%) | 0% | 38.3 | 321,910 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 32.97 per share. | 18 Dec 2020 | 7,441 | 281,120 (0%) | 0% | 33.0 | 245,339 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 37.21 per share. | 18 Dec 2020 | 4,300 | 308,412 (1%) | 0% | 37.2 | 159,991 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 36.03 per share. | 18 Dec 2020 | 2,864 | 312,712 (1%) | 0% | 36.0 | 103,191 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 33.92 per share. | 18 Dec 2020 | 2,310 | 317,390 (1%) | 0% | 33.9 | 78,359 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 34.90 per share. | 18 Dec 2020 | 1,814 | 315,576 (1%) | 0% | 34.9 | 63,306 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 32.09 per share. | 18 Dec 2020 | 1,439 | 288,561 (0%) | 0% | 32.1 | 46,178 | Common Stock |
| Frequency Therapeutics Inc | Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 33.82 per share. | 18 Dec 2020 | 1,120 | 280,000 (0%) | 0% | 33.8 | 37,879 | Common Stock |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2020 | 28,379 | 0 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2020 | 28,379 | 67,519 (0%) | 0% | 0 | Common Stock | |
| Intra-Cellular Therapies Inc | Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2020 | 20,000 | 0 | - | - | Stock Option (right to buy) |